Michael Dee Aslin

D.D.S. | Dentist



  
  3919 N Maple St, Spokane
  Washington, 99205-1349

  509-444-8200    509-444-7806 Maps & Directions
Michael Dee Aslin is a Spokane, Washington based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3919 N Maple St, Spokane. Patients can reach him at 509-444-8200.
Michael Dee Aslin is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Michael Dee Aslin speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Michael Dee Aslin
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:3919 N Maple St, Spokane,
Washington, 99205-1349
Phone:509-444-8200
Fax:509-444-7806
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 3375504533
Enrollment ID: I20171010001979
NPI Number: 1861614505
NPI Enumeration Date: 03 May, 2007
NPI Last Update On: 02 Apr, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 203 N Washington St Ste 300,
Spokane, Washington
Zip: 99201-0254
Phone Number: 509-444-8888
Fax Number: 509-444-7806
Patients can reach Michael Dee Aslin at 3919 N Maple St, Spokane, Washington or can call to book an appointment on 509-444-8200. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: